Pune, India -- (SBWire) -- 02/20/2019 --Overview of Cell Banking Outsourcing Market Research Report 2019
A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. The global Cell Banking Outsourcing market is valued at 4210 million USD in 2018 and is expected to reach 9440 million USD by the end of 2024, growing at a CAGR of 17.5% between 2019 and 2024.
Get a Sample PDF Report: @ https://bit.ly/2URU6BQ
Scope of the Report:
Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.
Cell banking is a process of replicating and storing cells for the purpose of future use. Storage of these cell samples can be utilized for research purposes and for surgical reconstruction of damaged body structures. Cells are frozen in cryovials at -196 degrees Celsius along with cryoprotection agents such as 10% solution of DMSO. Cell banking is most commonly used in stem cell research and therapy.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Banking Outsourcing.
This report studies the Cell Banking Outsourcing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Banking Outsourcing market by product type and applications/end industries.
Market Segment by Companies :
SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals, ViaCord, Thermo Fisher, Wuxi Apptec, CordLife, Esperite, Reliance Life Sciences, Lifecell, Cryo-Cell, Toxikon, Goodwin Biotechnology, Texcell, Cryo Stemcell
Market Segment by Regions :
North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type :
Stem Cell Banking, Non-stem Cell Banking
Market Segment by Applications :
Cell Bank Storage, Bank Characterization and Testing, Cell Bank Preparation
Get discount on this report @ https://bit.ly/2UZm1A0
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cell Banking Outsourcing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cell Banking Outsourcing, with price, sales, revenue and global market share of Cell Banking Outsourcing in 2017 and 2018.
Chapter 3, the Cell Banking Outsourcing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cell Banking Outsourcing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cell Banking Outsourcing market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cell Banking Outsourcing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
In the end, It includes the methodical description of the various factors such as the market growth and a detailed information about the different company's revenue, growth, technological developments, production, and the various other strategic developments.
Read Complete Report With TOC: @ https://bit.ly/2UVyrZv
Thus the Cell Banking Outsourcing Market Report serves as a valuable material for all industry competitors and individuals having a keen interest in Cell Banking Outsourcing Market study.
About Garner Insights
Garner Insights is a Market Intelligence and consulting firm with a comprehensive experience and rich knowledge of the market research industry.
Our vast repository of research reports across various categories, gives you a complete view of the ever-evolving trends and current topics worldwide. Our constant focus is on improving the data and finding innovative methods, which will help your business drive profitable growth.
Global Cell Banking Outsourcing Market Opportunity Assessment 2019-2024
Expected Explosive Growth for Global Cell Banking Outsourcing Market by 2019-2024: Major Key Players - SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals